Pancreatic Cancer Research

ResearcherJiaxing UniversityActive in the last 2 years

Xiaorong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5278-7189; OpenAlex author ID A5100630627. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. FBXO22-mediated ubiquitination of KLF10 promoting pancreatic cancer proliferation and invasion. Co-author DOI 10.1016/j.pan.2025.11.016↗
  2. The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis. Co-author DOI 10.1186/s12876-024-03581-5↗
  3. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Co-author DOI 10.3389/fonc.2022.1004212↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoguang Wang · 2 shared papers, 2025–2026 · strength 0.66
  2. Fenfen Jiang · 1 shared paper, 2026 · strength 0.36
  3. Lingyu Hu · 1 shared paper, 2025 · strength 0.30
  4. Wei Guo · 1 shared paper, 2025 · strength 0.30
  5. Fei Chen · 1 shared paper, 2022 · strength 0.16
  6. Zhengwei Song · 1 shared paper, 2022 · strength 0.16
  7. Xiaoguang Wang · 1 shared paper, 2022 · strength 0.16
  8. Peter Wang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.